Axogen (AXGN) Free Cash Flow (2010 - 2026)
Axogen's (AXGN) quarterly Free Cash Flow came in at -$1.2 million in Q1 2026, up 90.89% year-on-year from -$641208.8 in Q1 2025, and down 159.87% quarter-over-quarter from -$471000.0 in Q4 2025.
Axogen (AXGN) Free Cash Flow (2010 - 2026) Analysis & Trends
Axogen's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 90.89% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was $9.3 million, a 680.32% increase from a year earlier, with the FY2025 full-year figure at -$2.9 million, down 304.53% from the prior year.
- Free Cash Flow fell to -$1.2 million in Q1 2026 per AXGN's latest filing, from -$471000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $7.9 million in Q2 2025 and bottomed at -$13.4 million in Q1 2025.
- The 5-year median for Free Cash Flow is -$1.7 million (2023), against an average of -$3.4 million.
- Across the five-year window, Free Cash Flow sank 677.4% in 2022 and soared 1082.2% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$5.3 million in 2022, then soared by 68.17% to -$1.7 million in 2023, then jumped by 443.37% to $5.7 million in 2024, then plunged by 108.19% to -$471000.0 in 2025, then slumped by 159.87% to -$1.2 million in 2026.
- Per Business Quant, the three latest AXGN Free Cash Flow figures stand at -$1.2 million (Q1 2026), -$471000.0 (Q4 2025), and $3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -471,000.00 |
| Dec 31, 2025 | -471,000.00 |
| Sep 30, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Mar 31, 2025 | -13.44 Mn |
| Mar 31, 2025 | -13.44 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | 3.97 Mn |
| Sep 30, 2024 | 3.97 Mn |
| Jun 30, 2024 | 4.91 Mn |
| Jun 30, 2024 | 4.91 Mn |
| Mar 31, 2024 | -13.19 Mn |
| Mar 31, 2024 | -13.19 Mn |
| Dec 31, 2023 | -1.67 Mn |
| Dec 31, 2023 | -1.67 Mn |